Literature DB >> 28462152

Ocular Kaposi's sarcoma as the first manifestation of HIV infection.

E A Lusi1, P Guarascio2.   

Abstract

Entities:  

Year:  2017        PMID: 28462152      PMCID: PMC5406515          DOI: 10.1016/j.idcr.2017.02.011

Source DB:  PubMed          Journal:  IDCases        ISSN: 2214-2509


× No keyword cloud information.
A 51-year-old male presented with a three-months history of a raised lesion in the inferior eyelid of the right eye and small nodules of dark red colour present on his nose. The ocular lesion initially diagnosed as an ocular angioma, failed to respond to treatment and required further medical examinations and an immunological consult. A positive test for HIV, lower CD4+ cell count (148cells/μl), elevated HIV plasma levels (100.000 viral copies), established the diagnosis of AIDS. Histological examination detected the presence of spindle cells and the positivity for Kaposi-associated Herpes virus-8 confirmed the lesions as Kaposi’s sarcoma [1], [2], [3]. Visceral sarcoma lesions were also present in the ascending colon and gastric fundus. Treatment with antiretroviral therapy (dolutegravir and truvada) and the first cycle of doxorubicina was initiated immediately. Although Kaposi’s sarcoma was historically the harbinger of epidemics AIDS, is now rarely seen in HIV-positive patients as first presentation [4], [5]. In this case the ocular Kaposi sarcoma was the first manifestation of HIV infection and its initial diagnosis was completely misunderstood (Fig. 1).
Fig. 1

This picture illustrates an isolated conjunctival Kaposi’s sarcoma as primary presentation of AIDS. A raised ocular lesion and small nodules of dark red colour are visible.

This picture illustrates an isolated conjunctival Kaposi’s sarcoma as primary presentation of AIDS. A raised ocular lesion and small nodules of dark red colour are visible.
  5 in total

Review 1.  Inflammatory reactivation and angiogenicity of Kaposi's sarcoma-associated herpesvirus/HHV8: a missing link in the pathogenesis of acquired immunodeficiency syndrome-associated Kaposi's sarcoma.

Authors:  E A Mesri
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

Review 2.  Kaposi's sarcoma.

Authors:  K Antman; Y Chang
Journal:  N Engl J Med       Date:  2000-04-06       Impact factor: 91.245

Review 3.  Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.

Authors:  Paul G Rubinstein; David M Aboulafia; Andrew Zloza
Journal:  AIDS       Date:  2014-02-20       Impact factor: 4.177

Review 4.  Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.

Authors:  Ricardo Ney Oliveira Cobucci; Paulo Henrique Lima; Pollyana Carvalho de Souza; Vanessa Viana Costa; Maria da Conceição de Mesquita Cornetta; José Veríssimo Fernandes; Ana Katherine Gonçalves
Journal:  J Infect Public Health       Date:  2014-10-05       Impact factor: 3.718

5.  Origin of spindle-shaped cells in Kaposi sarcoma.

Authors:  M A Karasek
Journal:  Lymphology       Date:  1994-03       Impact factor: 1.286

  5 in total
  1 in total

1.  A Case of Ocular Kaposi's Sarcoma Successfully Treated with Highly Active Antiretroviral Therapy (HAART) Combined with Docetaxel.

Authors:  Chongfei Jin; Hamza Minhas; Amandeep Kaur; Sreenath Kodali; Vladimir Gotlieb
Journal:  Am J Case Rep       Date:  2018-09-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.